FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma.
Kwitkowski
Virginia E
VE
Division of Drug Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993-0002, USA. Virginia.Kwitkowski@fda.hhs.gov
Prowell
Tatiana M
TM
Ibrahim
Amna
A
Farrell
Ann T
AT
Justice
Robert
R
Mitchell
Shan Sun
SS
Sridhara
Rajeshwari
R
Pazdur
Richard
R